Espinoza Octavio bought LGND
February 28, 2024 · Form 4 insider transaction
Espinoza Octavio bought 325 shares of Ligand Pharmaceuticals Incorporated at $58.49 per share, a transaction worth $19.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
325
Price
$58.49
Total value
$19.0K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 28, 2024
Filing dateFebruary 29, 2024
Shares owned after29,895
OwnershipDirect
10b5-1 planNo
AmendedNo